SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-15
👔
Fulcrum Therapeutics, Inc.
@FULC_InsiderForm 4 Filing: TANG KEVIN Buys $891,067.48 of $FULC
INSIDER PURCHASE
⚡ MATERIALITY: 7/10
corporate issuer
Fulcrum Therapeutics, Inc.
Ticker: $FULC
Transaction Value
$891,067.48
Price/Share: $3.57
transaction date
2026-07-15
Shares: 249,946
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, TANG KEVIN, holds the title of 10% Owner at Fulcrum Therapeutics, Inc..
On 2026-07-15, the insider transacted 249,946 shares.The shares were transacted at a weighted average price of $3.57 per share, resulting in a total market-relevant value of $891,067.48.
Executive Summary Summary
TANG KEVIN (10% Owner) bought $891K of $FULC
Post-Transaction Position: 6,913,329 shares
SEC Accession No: 0001178579-26-000014 (CIK: 1178579)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.